NCT01711307 (AchillesRCT) is a NA clinical trial of operative in Ruptured Achilles Tendon, sponsored by Mark Glazebrook.

Who is sponsoring NCT01711307?

NCT01711307 is sponsored by Mark Glazebrook.

What drugs are being tested in NCT01711307?

Interventions in NCT01711307: operative, non-operative.

What condition does NCT01711307 study?

NCT01711307 studies Ruptured Achilles Tendon.

Is NCT01711307 still recruiting?

NCT01711307 is currently terminated. Last updated 9 July 2020.

Last reviewed 2020-07-09 · How we verify

NCT01711307: AchillesRCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon

Terminated NA Last updated 9 July 2020

What this trial tests

NA trial testing operative in Ruptured Achilles Tendon in 220 participants. Terminated before completion.

Timeline

1 October 2012

Primary endpoint
31 December 2019

30 June 2020

Quick facts

Lead sponsor	Mark Glazebrook
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	220
Start date	1 October 2012
Primary completion	31 December 2019
Estimated completion	30 June 2020
Sites	1 location across Canada

Drugs / interventions tested

operative
non-operative

Conditions studied

Ruptured Achilles Tendon — all drugs for Ruptured Achilles Tendon →

Sponsor

Mark Glazebrook

Who can join

18 and older, any sex, with Ruptured Achilles Tendon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed trial is a multi-centre prospective randomized controlled trial comparing outcomes of patients with acute Achilles tendon ruptures treated either non-operatively or with open operative tendon repair. All patients will undergo accelerated functional rehabilitation. The primary outcome measure is Achilles tendon re-rupture rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of operative

Trials testing the same drug.

NCT06454929 — Treatment of Displaced Medial Epicondyle Fractures In Children · NA · not yet recruiting
NCT02212054 — A Trial on Treatments of Hirschsprung Allied Disease · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01711307 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mark Glazebrook
Last refreshed: 9 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01711307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing